Biomedical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1-504-608-2390

Research Article - Biomedical Research (2017) Volume 28, Issue 22

Expressions of PS-2, CA153 and VEGF and clinical significance in patients with breast cancer

Objective: To observe the expression of Presenilin 2 (PS-2), CA153, and Vascular Endothelial Growth Factor (VEGF) of the patients with breast cancer and discuss the clinical implication.

Methods: The expression of PS-2 and VEGF were measured by immunohistochemistry; and the serum level of CA153 was measured by enzyme linked immune sorbent assay. Meanwhile, the associations between PS-2, CA153, VEGF and clinical pathologic features were evaluated.

Results: The positive expression rates of PS-2, CA153 and VEGF were 45.19%, 86.54%, 76.92% respectively. As a result of 0-4 level classification, the expressions of PS-2 and VEGF in the breast cancer tissues were statistically different with these in the normal tissue, p<0.05. There was positive correlation between the expressions of CA153 and VEGF in the breast cancer patients, which were higher than the expressions in the normal group, p<0.05. Besides, the expressions of CA153 and VEGF in the breast cancer patients with axillary lymph node metastasis were higher than the patients without metastasis, p=0.0027<0.05.

Conclusion: There are significant evidences that PS-2, CA153 and VEGF would be the independent risk factors, so as to be contributed to the predictions of the malignancy degree and metastasis of breast cancer.

Author(s): Li Zhixiang, Qian Jun, Li Jing, Zhu Chao

Abstract Full Text PDF

Get the App

best replica reviews